Back to Search
Start Over
Why PB28 Could Be a Covid 2019 Game Changer?
- Source :
-
ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 Aug 14; Vol. 11 (10), pp. 2048-2050. Date of Electronic Publication: 2020 Aug 14 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- PB28, a cyclohexylpiperazine derivative, could be a potential strategy for Covid 19 because in a recent study it has been found more active than hydroxychloroquine without interaction with cardiac proteins. PB28 has been designed, developed, and biologically evaluated in the past decade in our research group. A possible mechanism to explain its surprising anti-COVID-19 activity is suggested..<br />Competing Interests: The authors declare no competing financial interest.
Details
- Language :
- English
- ISSN :
- 1948-5875
- Volume :
- 11
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- ACS medicinal chemistry letters
- Publication Type :
- Academic Journal
- Accession number :
- 33052254
- Full Text :
- https://doi.org/10.1021/acsmedchemlett.0c00271